Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled study

Objective: To determine the efficacy of weekly treatment with oral azithromycin for 13 weeks on the severity and resolution of reactive arthritis (ReA). Methods: 186 patients from 12 countries were enrolled in a randomised, double blind, placebo controlled trial. Inclusion criteria were inflammatory...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Kvien, T, Gaston, J, Bardin, T, Butrimiene, I, Dijkmans, B, Leirisalo-Repo, M, Solakov, P, Altwegg, M, Mowinckel, P, Plan, P, Vischer, T
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2004
Soggetti:
Extended Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1755135/
https://ncbi.nlm.nih.gov/pubmed/15308521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2003.010710
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi